Contract Research and Manufacturing Service (CRAMS) Market in India 2025-2029

Contract Research And Manufacturing Service (CRAMS) Market In India 2025-2029

The contract research and manufacturing service (CRAMS) market in India is forecasted to grow by USD 17114.6 million during 2024-2029, accelerating at a CAGR of 11.8% during the forecast period. The report on the contract research and manufacturing service (CRAMS) market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by diverse range of service offerings by CRAMS providers, availability of cost-effective solutions for research, development, and manufacturing services, and presence of highly skilled workforce in pharmaceutical sciences and biotechnology.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit - https://www.technavio.com/report/report/india-contract-research-and-manufacturing-service-CRAMS-market-in-2024-2028-industry-analysis

Technavio's contract research and manufacturing service (CRAMS) market in India is segmented as below:

By Service

  • Manufacturing
  • Research
By Therapeutic Area
  • Cardiovascular
  • Infectious disease
  • Endocrine disease
  • Oncology
  • Others
By End-user
  • Pharmaceutical and biopharmaceutical companies
  • Medical device companies
  • Academic and research institutes
By Technology
  • Bioinformatics
  • Combinatorial chemistry
  • High-throughput screening
  • Spectroscopy
  • Others
By Geographical Landscape
  • APAC
This study identifies the technological advancements in CRAMS as one of the prime reasons driving the contract research and manufacturing service (CRAMS) market in India growth during the next few years. Also, increasing number of US fda-approved manufacturing facilities and increasing outsourcing of research and manufacturing activities by smes will lead to sizable demand in the market.

The report on the contract research and manufacturing service (CRAMS) market in India covers the following areas:
  • Contract Research And Manufacturing Service (CRAMS) Market in India sizing
  • Contract Research And Manufacturing Service (CRAMS) Market in India forecast
  • Contract Research And Manufacturing Service (CRAMS) Market in India industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract research and manufacturing service (CRAMS) market in India vendors that include Aragen Life Sciences Pvt. Ltd., Arch Pharmalabs Ltd., Aurobindo Pharma Ltd., Bhagwati Organics Pvt. Ltd., Biocon Ltd., Dhanuka Agritech Ltd., Dishman Carbogen Amcis Ltd., Divis Laboratories Ltd., Ind-Swift Laboratories Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Merck and Co. Inc., MSN Laboratories, Murli Krishna Pharma Pvt. Ltd., Onyx Scientific Ltd., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., TCG Lifesciences Pvt. Ltd., and Wockhardt Ltd.. Also, the contract research and manufacturing service (CRAMS) market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Service
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India: Year-over-year growth 2024-2029 (%)
Data Table on India: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Contract Research And Manufacturing Service (CRAMS) Market in India 2019 - 2023
Historic Market Size - Data Table on Contract Research And Manufacturing Service (CRAMS) Market in India 2019 - 2023 ($ million)
5.2 Service segment analysis 2019 - 2023
Historic Market Size - Service Segment 2019 - 2023 ($ million)
5.3 Therapeutic Area segment analysis 2019 - 2023
Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Technology segment analysis 2019 - 2023
Historic Market Size - Technology Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Contract Research and Manufacturing Service (CRAMS) Market in India
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Service
8.1 Market segments
Chart on Service - Market share 2024-2029 (%)
Data Table on Service - Market share 2024-2029 (%)
8.2 Comparison by Service
Chart on Comparison by Service
Data Table on Comparison by Service
8.3 Manufacturing - Market size and forecast 2024-2029
Chart on Manufacturing - Market size and forecast 2024-2029 ($ million)
Data Table on Manufacturing - Market size and forecast 2024-2029 ($ million)
Chart on Manufacturing - Year-over-year growth 2024-2029 (%)
Data Table on Manufacturing - Year-over-year growth 2024-2029 (%)
8.4 Research - Market size and forecast 2024-2029
Chart on Research - Market size and forecast 2024-2029 ($ million)
Data Table on Research - Market size and forecast 2024-2029 ($ million)
Chart on Research - Year-over-year growth 2024-2029 (%)
Data Table on Research - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Service
Market opportunity by Service ($ million)
Data Table on Market opportunity by Service ($ million)
9 Market Segmentation by Therapeutic Area
9.1 Market segments
Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)
9.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
9.3 Cardiovascular - Market size and forecast 2024-2029
Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
9.4 Infectious disease - Market size and forecast 2024-2029
Chart on Infectious disease - Market size and forecast 2024-2029 ($ million)
Data Table on Infectious disease - Market size and forecast 2024-2029 ($ million)
Chart on Infectious disease - Year-over-year growth 2024-2029 (%)
Data Table on Infectious disease - Year-over-year growth 2024-2029 (%)
9.5 Endocrine disease - Market size and forecast 2024-2029
Chart on Endocrine disease - Market size and forecast 2024-2029 ($ million)
Data Table on Endocrine disease - Market size and forecast 2024-2029 ($ million)
Chart on Endocrine disease - Year-over-year growth 2024-2029 (%)
Data Table on Endocrine disease - Year-over-year growth 2024-2029 (%)
9.6 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
10 Market Segmentation by End-user
10.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029
Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
10.4 Medical device companies - Market size and forecast 2024-2029
Chart on Medical device companies - Market size and forecast 2024-2029 ($ million)
Data Table on Medical device companies - Market size and forecast 2024-2029 ($ million)
Chart on Medical device companies - Year-over-year growth 2024-2029 (%)
Data Table on Medical device companies - Year-over-year growth 2024-2029 (%)
10.5 Academic and research institutes - Market size and forecast 2024-2029
Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
11 Market Segmentation by Technology
11.1 Market segments
Chart on Technology - Market share 2024-2029 (%)
Data Table on Technology - Market share 2024-2029 (%)
11.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
11.3 Bioinformatics - Market size and forecast 2024-2029
Chart on Bioinformatics - Market size and forecast 2024-2029 ($ million)
Data Table on Bioinformatics - Market size and forecast 2024-2029 ($ million)
Chart on Bioinformatics - Year-over-year growth 2024-2029 (%)
Data Table on Bioinformatics - Year-over-year growth 2024-2029 (%)
11.4 Combinatorial chemistry - Market size and forecast 2024-2029
Chart on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million)
Data Table on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million)
Chart on Combinatorial chemistry - Year-over-year growth 2024-2029 (%)
Data Table on Combinatorial chemistry - Year-over-year growth 2024-2029 (%)
11.5 High-throughput screening - Market size and forecast 2024-2029
Chart on High-throughput screening - Market size and forecast 2024-2029 ($ million)
Data Table on High-throughput screening - Market size and forecast 2024-2029 ($ million)
Chart on High-throughput screening - Year-over-year growth 2024-2029 (%)
Data Table on High-throughput screening - Year-over-year growth 2024-2029 (%)
11.6 Spectroscopy - Market size and forecast 2024-2029
Chart on Spectroscopy - Market size and forecast 2024-2029 ($ million)
Data Table on Spectroscopy - Market size and forecast 2024-2029 ($ million)
Chart on Spectroscopy - Year-over-year growth 2024-2029 (%)
Data Table on Spectroscopy - Year-over-year growth 2024-2029 (%)
11.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
11.8 Market opportunity by Technology
Market opportunity by Technology ($ million)
Data Table on Market opportunity by Technology ($ million)
12 Customer Landscape
12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Aragen Life Sciences Pvt. Ltd.
Aragen Life Sciences Pvt. Ltd. - Overview
Aragen Life Sciences Pvt. Ltd. - Product / Service
Aragen Life Sciences Pvt. Ltd. - Key offerings
SWOT
15.5 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
SWOT
15.6 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
SWOT
15.7 Dhanuka Agritech Ltd.
Dhanuka Agritech Ltd. - Overview
Dhanuka Agritech Ltd. - Business segments
Dhanuka Agritech Ltd. - Key offerings
Dhanuka Agritech Ltd. - Segment focus
SWOT
15.8 Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Ltd. - Overview
Dishman Carbogen Amcis Ltd. - Business segments
Dishman Carbogen Amcis Ltd. - Key offerings
Dishman Carbogen Amcis Ltd. - Segment focus
SWOT
15.9 Divis Laboratories Ltd.
Divis Laboratories Ltd. - Overview
Divis Laboratories Ltd. - Product / Service
Divis Laboratories Ltd. - Key offerings
SWOT
15.10 Jubilant Pharmova Ltd.
Jubilant Pharmova Ltd. - Overview
Jubilant Pharmova Ltd. - Business segments
Jubilant Pharmova Ltd. - Key news
Jubilant Pharmova Ltd. - Key offerings
Jubilant Pharmova Ltd. - Segment focus
SWOT
15.11 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
15.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.13 MSN Laboratories
MSN Laboratories - Overview
MSN Laboratories - Product / Service
MSN Laboratories - Key offerings
SWOT
15.14 Onyx Scientific Ltd.
Onyx Scientific Ltd. - Overview
Onyx Scientific Ltd. - Product / Service
Onyx Scientific Ltd. - Key offerings
SWOT
15.15 Piramal Enterprises Ltd.
Piramal Enterprises Ltd. - Overview
Piramal Enterprises Ltd. - Product / Service
Piramal Enterprises Ltd. - Key offerings
SWOT
15.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
15.17 TCG Lifesciences Pvt. Ltd.
TCG Lifesciences Pvt. Ltd. - Overview
TCG Lifesciences Pvt. Ltd. - Product / Service
TCG Lifesciences Pvt. Ltd. - Key offerings
SWOT
15.18 Wockhardt Ltd.
Wockhardt Ltd. - Overview
Wockhardt Ltd. - Business segments
Wockhardt Ltd. - Key offerings
Wockhardt Ltd. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Service
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Market Segmentation by Technology
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits10: Overview on criticality of inputs and factors of differentiation
Exhibits11: Overview on factors of disruption
Exhibits12: Impact of drivers and challenges in 2024 and 2029
Exhibits13: Parent Market
Exhibits14: Data Table on - Parent Market
Exhibits15: Market characteristics analysis
Exhibits16: Value chain analysis
Exhibits17: Offerings of companies included in the market definition
Exhibits18: Market segments
Exhibits19: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits20: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits21: Chart on India: Year-over-year growth 2024-2029 (%)
Exhibits22: Data Table on India: Year-over-year growth 2024-2029 (%)
Exhibits23: Historic Market Size - Data Table on Contract Research And Manufacturing Service (CRAMS) Market in India 2019 - 2023 ($ million)
Exhibits24: Historic Market Size - Service Segment 2019 - 2023 ($ million)
Exhibits25: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Technology Segment 2019 - 2023 ($ million)
Exhibits28: Five forces analysis - Comparison between 2024 and 2029
Exhibits29: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits30: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits31: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits32: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits33: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits34: Chart on Market condition - Five forces 2024 and 2029
Exhibits35: Chart on Service - Market share 2024-2029 (%)
Exhibits36: Data Table on Service - Market share 2024-2029 (%)
Exhibits37: Chart on Comparison by Service
Exhibits38: Data Table on Comparison by Service
Exhibits39: Chart on Manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits40: Data Table on Manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits41: Chart on Manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits42: Data Table on Manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits43: Chart on Research - Market size and forecast 2024-2029 ($ million)
Exhibits44: Data Table on Research - Market size and forecast 2024-2029 ($ million)
Exhibits45: Chart on Research - Year-over-year growth 2024-2029 (%)
Exhibits46: Data Table on Research - Year-over-year growth 2024-2029 (%)
Exhibits47: Market opportunity by Service ($ million)
Exhibits48: Data Table on Market opportunity by Service ($ million)
Exhibits49: Chart on Therapeutic Area - Market share 2024-2029 (%)
Exhibits50: Data Table on Therapeutic Area - Market share 2024-2029 (%)
Exhibits51: Chart on Comparison by Therapeutic Area
Exhibits52: Data Table on Comparison by Therapeutic Area
Exhibits53: Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Exhibits54: Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Exhibits55: Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits56: Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits57: Chart on Infectious disease - Market size and forecast 2024-2029 ($ million)
Exhibits58: Data Table on Infectious disease - Market size and forecast 2024-2029 ($ million)
Exhibits59: Chart on Infectious disease - Year-over-year growth 2024-2029 (%)
Exhibits60: Data Table on Infectious disease - Year-over-year growth 2024-2029 (%)
Exhibits61: Chart on Endocrine disease - Market size and forecast 2024-2029 ($ million)
Exhibits62: Data Table on Endocrine disease - Market size and forecast 2024-2029 ($ million)
Exhibits63: Chart on Endocrine disease - Year-over-year growth 2024-2029 (%)
Exhibits64: Data Table on Endocrine disease - Year-over-year growth 2024-2029 (%)
Exhibits65: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits66: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits67: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits68: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits69: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits70: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits71: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits72: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits73: Market opportunity by Therapeutic Area ($ million)
Exhibits74: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibits75: Chart on End-user - Market share 2024-2029 (%)
Exhibits76: Data Table on End-user - Market share 2024-2029 (%)
Exhibits77: Chart on Comparison by End-user
Exhibits78: Data Table on Comparison by End-user
Exhibits79: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
Exhibits80: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
Exhibits81: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
Exhibits82: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
Exhibits83: Chart on Medical device companies - Market size and forecast 2024-2029 ($ million)
Exhibits84: Data Table on Medical device companies - Market size and forecast 2024-2029 ($ million)
Exhibits85: Chart on Medical device companies - Year-over-year growth 2024-2029 (%)
Exhibits86: Data Table on Medical device companies - Year-over-year growth 2024-2029 (%)
Exhibits87: Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits88: Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits89: Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits90: Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits91: Market opportunity by End-user ($ million)
Exhibits92: Data Table on Market opportunity by End-user ($ million)
Exhibits93: Chart on Technology - Market share 2024-2029 (%)
Exhibits94: Data Table on Technology - Market share 2024-2029 (%)
Exhibits95: Chart on Comparison by Technology
Exhibits96: Data Table on Comparison by Technology
Exhibits97: Chart on Bioinformatics - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Bioinformatics - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Bioinformatics - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Bioinformatics - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Combinatorial chemistry - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Combinatorial chemistry - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Combinatorial chemistry - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on High-throughput screening - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on High-throughput screening - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on High-throughput screening - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on High-throughput screening - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Spectroscopy - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Spectroscopy - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Spectroscopy - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Spectroscopy - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits117: Market opportunity by Technology ($ million)
Exhibits118: Data Table on Market opportunity by Technology ($ million)
Exhibits119: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits120: Impact of drivers and challenges in 2024 and 2029
Exhibits121: Overview on criticality of inputs and factors of differentiation
Exhibits122: Overview on factors of disruption
Exhibits123: Impact of key risks on business
Exhibits124: Companies covered
Exhibits125: Company ranking index
Exhibits126: Matrix on companies position and classification
Exhibits127: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibits128: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibits129: Aragen Life Sciences Pvt. Ltd. - Key offerings
Exhibits130: SWOT
Exhibits131: Aurobindo Pharma Ltd. - Overview
Exhibits132: Aurobindo Pharma Ltd. - Product / Service
Exhibits133: Aurobindo Pharma Ltd. - Key offerings
Exhibits134: SWOT
Exhibits135: Biocon Ltd. - Overview
Exhibits136: Biocon Ltd. - Business segments
Exhibits137: Biocon Ltd. - Key offerings
Exhibits138: Biocon Ltd. - Segment focus
Exhibits139: SWOT
Exhibits140: Dhanuka Agritech Ltd. - Overview
Exhibits141: Dhanuka Agritech Ltd. - Business segments
Exhibits142: Dhanuka Agritech Ltd. - Key offerings
Exhibits143: Dhanuka Agritech Ltd. - Segment focus
Exhibits144: SWOT
Exhibits145: Dishman Carbogen Amcis Ltd. - Overview
Exhibits146: Dishman Carbogen Amcis Ltd. - Business segments
Exhibits147: Dishman Carbogen Amcis Ltd. - Key offerings
Exhibits148: Dishman Carbogen Amcis Ltd. - Segment focus
Exhibits149: SWOT
Exhibits150: Divis Laboratories Ltd. - Overview
Exhibits151: Divis Laboratories Ltd. - Product / Service
Exhibits152: Divis Laboratories Ltd. - Key offerings
Exhibits153: SWOT
Exhibits154: Jubilant Pharmova Ltd. - Overview
Exhibits155: Jubilant Pharmova Ltd. - Business segments
Exhibits156: Jubilant Pharmova Ltd. - Key news
Exhibits157: Jubilant Pharmova Ltd. - Key offerings
Exhibits158: Jubilant Pharmova Ltd. - Segment focus
Exhibits159: SWOT
Exhibits160: Lupin Ltd. - Overview
Exhibits161: Lupin Ltd. - Business segments
Exhibits162: Lupin Ltd. - Key news
Exhibits163: Lupin Ltd. - Key offerings
Exhibits164: Lupin Ltd. - Segment focus
Exhibits165: SWOT
Exhibits166: Merck and Co. Inc. - Overview
Exhibits167: Merck and Co. Inc. - Business segments
Exhibits168: Merck and Co. Inc. - Key news
Exhibits169: Merck and Co. Inc. - Key offerings
Exhibits170: Merck and Co. Inc. - Segment focus
Exhibits171: SWOT
Exhibits172: MSN Laboratories - Overview
Exhibits173: MSN Laboratories - Product / Service
Exhibits174: MSN Laboratories - Key offerings
Exhibits175: SWOT
Exhibits176: Onyx Scientific Ltd. - Overview
Exhibits177: Onyx Scientific Ltd. - Product / Service
Exhibits178: Onyx Scientific Ltd. - Key offerings
Exhibits179: SWOT
Exhibits180: Piramal Enterprises Ltd. - Overview
Exhibits181: Piramal Enterprises Ltd. - Product / Service
Exhibits182: Piramal Enterprises Ltd. - Key offerings
Exhibits183: SWOT
Exhibits184: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits185: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits186: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits187: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits188: SWOT
Exhibits189: TCG Lifesciences Pvt. Ltd. - Overview
Exhibits190: TCG Lifesciences Pvt. Ltd. - Product / Service
Exhibits191: TCG Lifesciences Pvt. Ltd. - Key offerings
Exhibits192: SWOT
Exhibits193: Wockhardt Ltd. - Overview
Exhibits194: Wockhardt Ltd. - Business segments
Exhibits195: Wockhardt Ltd. - Key offerings
Exhibits196: Wockhardt Ltd. - Segment focus
Exhibits197: SWOT
Exhibits198: Inclusions checklist
Exhibits199: Exclusions checklist
Exhibits200: Currency conversion rates for US$
Exhibits201: Research methodology
Exhibits202: Information sources
Exhibits203: Data validation
Exhibits204: Validation techniques employed for market sizing
Exhibits205: Data synthesis
Exhibits206: 360 degree market analysis
Exhibits207: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings